Form 4: NeuroOne Medical Technologies Executive Sells Shares to Cover Tax Obligations

Mark Christianson, Business Development Director at NeuroOne Medical Technologies, disposed of 90 shares of common stock on February 29, 2024, to cover tax obligations.

Summary

• On February 29, 2024, Mark Christianson, the Business Development Director of NeuroOne Medical Technologies Corp, disposed of 90 shares of common stock.
• The transaction was executed to cover tax obligations arising from the vesting of restricted stock units or similar equity awards.
• The shares were sold at a price of $1.21 per share.
• Following the transaction, Christianson directly owns 325,324 shares of NeuroOne Medical Technologies Corp.
• The transaction was reported on March 4, 2024.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing related to an insider stock transaction. It doesn't convey strong positive or negative sentiment about the company's performance or future prospects.

Industry Context

Form 4 filings are standard disclosures required by the SEC when company insiders, like officers and directors, trade their company's stock. These filings provide transparency into insider transactions and are closely watched by investors for signals about a company's prospects.

Stakeholder Impact

• The transaction is unlikely to have a significant impact on stakeholders, as it involves a small number of shares and is related to tax obligations.

Key Dates